Home arrow Features/Opinion arrow This is What a Real Cost/Quality Decision Looks Like - HCPMR
hr08000-152x558.gif
This is What a Real Cost/Quality Decision Looks Like - HCPMR E-mail to friends
(0 votes)
Robert Laszewski, Health Care Policy and Marketplace Review, Aug. 8, 2008

The UK's National Institute for Health and Clinical Excellence (NICE) has decided in a preliminary ruling that four drugs used for the treatment of advanced kidney cancer are not effective enough and they won't be paid for by the National Health Service.

Now before someone just claims this is what single-payer health care plans do all the time, let me be clear that NICE is an organization that has largely gained the respect of the world health community. Andrew Dillon, NICE's director, participated in a conference on technology evaluation I chaired a few years ago and the domestic audience from business and policy was more than impressed with their work.

These guys are trying to do the right thing and using extraordinary means to do it. They don't make arbitrary and bureaucratic decisions--they follow the science.

Read More

Digg!Del.icio.us!Google!Live!Facebook!StumbleUpon!Yahoo!Netvouz!Ma.gnolia!



Submit your own comment

Leave a Comment
Name:
E-mail:
Comment Title:
Comment:

Code:* Code
Plan Comparison Grid
image

Featured Podcast

Kim Slocum
Current State and Prospects for Consumer Directed Health Care Kim D. Slocum, President of KDS Consulting speaks with Malorye Allison, editor-in-chief of ReformPlans.com.
listen

More Podcasts

More Podcasts